Long-term treatment benefits with tiotropium in COPD patients with and without short-term bronchodilator responses.
about
Tiotropium versus placebo for chronic obstructive pulmonary diseaseLong-acting inhaled therapy (beta-agonists, anticholinergics and steroids) for COPD: a network meta-analysisTiotropium versus placebo for chronic obstructive pulmonary diseaseLong-acting beta2-agonists for poorly reversible chronic obstructive pulmonary diseaseIpratropium bromide versus long-acting beta-2 agonists for stable chronic obstructive pulmonary diseaseTiotropium for stable chronic obstructive pulmonary diseaseAre Smoking Cessation Treatments Associated with Suicidality Risk? An OverviewTiotropium (Spiriva): a once-daily inhaled anticholinergic medication for chronic obstructive pulmonary diseaseEffectiveness of the Assessment of Burden of Chronic Obstructive Pulmonary Disease (ABC) tool: study protocol of a cluster randomised trial in primary and secondary careThe combination of umeclidinium bromide and vilanterol in the management of chronic obstructive pulmonary disease: current evidence and future prospects.Acute bronchodilator responsiveness and health outcomes in COPD patients in the UPLIFT trial.Acute bronchodilator responses decline progressively over 4 years in patients with moderate to very severe COPD.Putting health status guided COPD management to the test: protocol of the MARCH study.Tiotropium bromide, a new, once-daily inhaled anticholinergic bronchodilator for chronic-obstructive pulmonary disease.Maintenance pharmacotherapy of chronic obstructive pulmonary disease: an evidence-based approach.Impact of Long-Term Tiotropium Bromide Therapy on Annual Lung Function Decline in Adult Patients with Cystic FibrosisTiotropium for stable chronic obstructive pulmonary disease: A meta-analysis.Tiotropium: a bronchodilator for chronic obstructive pulmonary disease.Features of COPD patients by comparing CAT with mMRC: a retrospective, cross-sectional study.Role of tiotropium in the treatment of COPD.Effectiveness of the Assessment of Burden of COPD (ABC) tool on health-related quality of life in patients with COPD: a cluster randomised controlled trial in primary and hospital care.Guidelines for diagnosis and management of chronic obstructive pulmonary disease: Joint ICS/NCCP (I) recommendations.Bronchodilator reversibility in patients with COPD revisited: short-term reproducibilitySequential comparison of tiotropium to high-dose ipratropium in patients with chronic obstructive pulmonary disease in a practice setting.Effects of long-term bronchodilators in bronchiectasis patients with airflow limitation based on bronchodilator response at baselineImmediate salbutamol responsiveness does not predict long-term benefits of indacaterol in patients with chronic obstructive pulmonary disease.Potential for long-acting muscarinic antagonists in chronic obstructive pulmonary disease.Tiotropium bromide for chronic obstructive pulmonary disease.Impact of tiotropium on the course of moderate-to-very severe chronic obstructive pulmonary disease: the UPLIFT trial.The efficacy of tiotropium as a steroid-sparing agent in severe asthma.Tiotropium bromide: an update.Formoterol and tiotropium compared with tiotropium alone for treatment of COPD.Isocapnic cold air challenge in patients with COPD: are there any predisposing factors?Additive benefits of tiotropium in COPD patients treated with long-acting beta agonists and corticosteroids.Diagnostic value of fractional exhaled nitric oxide for asthma-chronic obstructive pulmonary disease overlap syndrome.Characteristics and risk factors for inconsistency between the risk of exacerbations and the severity of airflow limitation in COPD based on GOLD 2017: A retrospective, cross-sectional study.
P2860
Q24194833-C9A4CADD-DADE-407B-AAE1-E6EC7ADA7061Q24197853-AF6033B6-849B-4CF2-8CD1-A2E42FD1DFFDQ24202175-E7EB69CF-4934-4779-A6E6-13F4F944D093Q24245141-7E386EFA-713B-4985-BC74-47934726E7A0Q24245413-7ABDE979-2A7C-4106-99B5-A73DC3AA1E51Q24246991-4B443285-497D-4A6F-B927-37D98BACC17FQ26747804-643DAD88-A76E-4885-85DB-BDB57C01CBF3Q33944981-95929107-B606-412B-8659-C0F1AD364148Q34033143-CC5DC6DC-49CF-410F-BA9C-6FF3E38D7153Q34368537-24476B6A-407B-4E4C-9C16-0EEF618730F4Q34521884-4A97E02C-02BF-41CA-A6B4-0914BC8E5537Q34571675-E013089A-9892-489A-9C3E-1F7A4BDFFBE0Q34798279-F8CB3EBE-3B33-43FA-9F6D-1D3C4CAB206EQ35841607-4F3A0706-1950-4791-874E-6EE5E6D0310EQ36040655-842DDE67-4B56-4013-8B33-949AAD5CBC5CQ36063173-805015FC-6622-4044-AB4F-8E3E77608CC9Q36184259-6E09A8EF-651E-4813-A91A-96AA4C6D35F5Q36200675-210A5623-58A7-431A-8226-9739B72DE506Q36250075-60E34D00-9F5C-47DA-9C86-82D26B2967F9Q37017516-E2053A15-D07C-43BC-8733-8103E0677DF7Q37100837-5A41977E-FBB9-4944-8EFB-3927B0A1C9C1Q37177278-9CE47A85-BFCC-4991-BA62-A4FDB981ED81Q37229628-0F053F12-6512-4CD3-B3F4-237FB6B17702Q37408475-B74944A6-0194-4331-AFA4-7F0E834F6DC3Q37409755-851C5AF8-DB42-4A28-8AA4-806F55D6E470Q37615959-03771F01-F31A-47BB-84AB-AC7160566E42Q37667100-31A14D69-7ADC-4756-BC99-BF38BA482B23Q37755016-2C399352-548A-4A7A-AA49-E2EC1CA9BB08Q37762827-326FBFF5-5A3A-428A-9E33-AEC002528898Q41880974-F0A73A94-3B04-42B8-90C5-5831E357FD3BQ43124360-AC5BB123-6C02-4ED0-B290-232DDDDE36A4Q43765049-96312135-31C6-4987-B7FC-4AB2C3A475D5Q46528024-8B2BB54F-147D-431E-88A1-81787A030D62Q51143982-964BB95C-523A-404A-9851-8B5DDAA47568Q55190512-A7F28023-9F0E-4CEC-89FA-512B07AA0502Q55331880-E852D2B0-9DEA-4107-B699-2AB33D327AFF
P2860
Long-term treatment benefits with tiotropium in COPD patients with and without short-term bronchodilator responses.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Long-term treatment benefits w ...... term bronchodilator responses.
@en
Long-term treatment benefits w ...... term bronchodilator responses.
@nl
type
label
Long-term treatment benefits w ...... term bronchodilator responses.
@en
Long-term treatment benefits w ...... term bronchodilator responses.
@nl
prefLabel
Long-term treatment benefits w ...... term bronchodilator responses.
@en
Long-term treatment benefits w ...... term bronchodilator responses.
@nl
P356
P1433
P1476
Long-term treatment benefits w ...... term bronchodilator responses.
@en
P2093
Donald Tashkin
Steven Kesten
P304
P356
10.1378/CHEST.123.5.1441
P407
P577
2003-05-01T00:00:00Z